NeuroSigma Announces that Enrollment Commences in Two

Trials recruiting subjects at UCLA and Seattle Children’s Hospital in the United States, and at King’s College London and the University of Southampton in...

Related Keywords

United States ,United Kingdom ,London ,City Of ,Ian Cook ,Colin Kealey ,Mark Stein ,James Mcgough ,King College London ,University Of California Los Angeles ,Behavioral Sciences At Seattle Children Hospital ,Neurosigma Inc ,Semel Institute For Neuroscience ,Europe Qs World University Rankings ,National Institutes Of Mental Health ,Semel Institute ,Department Of Health ,Research Council ,Terry Semel Institute For Neuroscience ,University Of Southampton ,United Kingdom National Institute For Health Research ,United Kingdom Research ,Her Co ,National Institutes Of Health ,Biobehavioral Sciences ,David Geffen School Of Medicine ,Department Of Psychiatry ,National Institute For Health Research ,Institute Of Psychiatry ,Seattle Children ,College London ,National Institutes ,Mental Health ,National Institute ,Health Research ,Los Angeles Based ,Chief Medical ,Chief Executive Officer ,Caregivers Interested ,University Rankings ,United Kingdom Aid ,Medical Research Council ,California Los Angeles ,World Report ,David Geffen School ,Terry Semel Institute ,Human Behavior ,Geffen School ,Medicine Department ,Resnick Neuropsychiatric Hospital ,External Trigeminal Nerve Stimulation ,Principal Investigator ,Sandra Loo ,Her Co Principal Investigators ,Clinical Psychiatry ,Behavioral Sciences ,Neurosigma ,Nc ,Adhd ,Bioelectronics ,Biotechnology ,Dhd Gems ,Cla ,Chimh ,Kings College ,Epilepsy ,Biotech ,Medical Devices ,Parc ,Nihr ,Kittens ,Euro ,